企業

Biohaven

フォロー構造マップを開くこれについて質問この企業をリサーチ

概要

本社: US

Biohaven の構造

Biohaven

企業

上流供給と依存3

同業競合と提携2

自社製品と技術2

関係

矢印は関係の方向を示します。分野で絞り込めます。

Biohavenと協定 →Ono Pharma
企業 · Ono Pharma根拠 1
事実90%
証拠を見る
- 企業開示PR Newswire news releases2026-10-08 16:00
  Under the terms of the agreement, Ono will obtain an exclusive license to develop and commercialize BHV-1300, BHV-1310, and BHV-1320
  出典を見る
BHV-1310の一部 →Biohaven
製品 · BHV-1310根拠 1
事実90%
証拠を見る
- 企業開示PR Newswire news releases2026-10-08 16:00
  extending the breadth and durability of Biohaven's MoDE IgG degrader portfolio
  出典を見る
BHV-1320の一部 →Biohaven
製品 · BHV-1320根拠 1
事実90%
証拠を見る
- 企業開示PR Newswire news releases2026-10-08 16:00
  extending the breadth and durability of Biohaven's MoDE IgG degrader portfolio
  出典を見る
Biohavenを使用 →MoDE
技術 · MoDE根拠 1
事実90%
証拠を見る
- 企業開示PR Newswire news releases2026-10-08 16:00
  Biohaven's MoDE platform is the first clinically validated technology enabling the targeted degradation of disease-causing proteins in the extracellular space.
  出典を見る
Biohavenを使用 →TRAP
技術 · TRAP根拠 1
事実90%
証拠を見る
- 企業開示PR Newswire news releases2026-10-08 16:00
  Biohaven's next-generation TRAP (Targeted Removal of Aberrant Protein) degraders extend the platform with highly selective molecules, each engineered to remove a single specific disease-causing protein.
  出典を見る
Biohavenで事業展開 →immunology
産業 · immunology根拠 1
事実90%
証拠を見る
- 企業開示PR Newswire news releases2026-10-08 16:00
  Biohaven Ltd. (NYSE: BHVN) is a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments across immunology, neuroscience, and oncology.
  出典を見る
Biohavenで事業展開 →neuroscience
産業 · neuroscience根拠 1
事実90%
証拠を見る
- 企業開示PR Newswire news releases2026-10-08 16:00
  Biohaven Ltd. (NYSE: BHVN) is a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments across immunology, neuroscience, and oncology.
  出典を見る
Biohavenで事業展開 →oncology
産業 · oncology根拠 1
事実90%
証拠を見る
- 企業開示PR Newswire news releases2026-10-08 16:00
  Biohaven Ltd. (NYSE: BHVN) is a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments across immunology, neuroscience, and oncology.
  出典を見る

13 件中 1 から 8 件を表示

主張

出典とともに結論を確認し、項目を開いて証拠を読めます。

事実根拠 1

で事業展開neuroscience

Biohaven Ltd. (NYSE: BHVN) is a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments across immunology, neuroscience, and oncology.